A real-world data study of 170 cases of liver cancer treated with heavy ion therapy in Wuwei reveals survival breakthroughs, with a median survival period of 37 months and a 5-year survival rate of 41.01%, demonstrating the outstanding value of China's advanced technology in the treatment of liver cancer.

Brain tumors are the focus and difficulty in the field of radiation therapy, mainly including two types: primary brain gliomas and secondary brain metastases. The Wuwei Heavy Ion Center, relying on China's first heavy (carbon) ion therapy system, has accumulated rich clinical experience in the treatment of brain tumors. Since the first patient received heavy (carbon) ion therapy in November 2018, as of March 2026, the center has treated a total of 198 patients with brain tumors, including 76 patients with brain gliomas and 122 patients with brain metastases, totaling 198 cases of brain tumors.

Analysis of the therapeutic effect of (carbon) ion therapy for 164 sarcoma patients at the Wuwei Ion Medical Center, with a local control rate approaching 100% and significant survival rates, suitable for complex locations and refractory sarcomas, demonstrating high safety and efficacy.

The Gansu Wuer Heavy Ion Cancer Center has completed 345 cases of pancreatic cancer treatment, with a median survival period of 17 months, demonstrating the significant advantages of domestic heavy ion technology in the treatment of advanced pancreatic cancer, becoming the largest in the country.

Clinical analysis of carbon ion therapy for 78 esophageal cancer patients at the Wuwei Heavy Ion Medical Center showed significant treatment effects and improved survival rates, especially showing obvious advantages for advanced patients.

Analysis of the Effect of Photon Therapy in 348 Patients with Esophageal Cancer at the Wuwei Tumor Hospital in Gansu Province, Evaluating the Median Survival Period of 23 Months, 5-Year Survival Rate of 22.9%, which is Better than Traditional Radiotherapy Schemes, Providing Data Support for Modern Precise Radiotherapy.

Heavy (carbon) ion therapy for prostate cancer: precise blasting, tumor elimination in three weeks, better protection of sexual function. Wuwei Heavy Ion Center provides advanced treatment options, with remarkable efficacy, mild side effects, preservation of patients' sexual function, and improved quality of life.

Clinical Analysis of 345 Cases of Pancreatic Cancer Treated with Heavy Ion (Carbon Ion) Therapy at the Wuwei Heavy Ion Medical Center, covering typical cases, survival data, and efficacy evaluation, demonstrating the advanced application and significant effectiveness of heavy ion therapy in pancreatic cancer.